Abstract:Objective To explore the efficacy of venlafaxine in prophylaxis and treatment of different TCM syndrome types of major depressive disorder. Methods From January 2015 to May 2017,thirty stagnation of liver-qi type and twenty-five insufficiency of heart and spleen type of patients with depression were recruited and treated by venlafaxine. The treatment course was six weeks. The efficacy was evaluated by Hamilton Depression Scale(HAMD)and Rating Scale for Side Effects(SERS). Results There were no statistically significant differences in age,gender,education,family history,course of the disease and HAMD at baseline between the stagnation of liver-qi type group and the insufficiency of heart and spleen type group(P>0.05). The HAMD scores of the two groups were significantly decreased at two,four,six weeks after venlafaxine treatment;the HAMD scores of stagnation of liver-qi type group were significantly lower than that of insufficiency of heart and spleen type group at the second week,the fourth week and the sixth week(all P<0.001). After six weeks of treatment,the scores of anxiety or somatization,cognitive impairment,retardation and hopelessness factors decreased more in the stagnation of liver-qi type group than that in the insufficiency of heart and spleen type group(P<0.05). The scores of SERS have no statistically significant difference between the two groups(3.60±4.98 vs.3.16±2.93)(P>0.05). Conclusion Venlafaxine has some treatment effect both on the stagnation of liver-qi type and the insufficiency of heart and spleen type of patients with depression,but better in the stagnation of liver-qi type.
刘兰英, 骆利元, 朱春青, 王佩蓉, 杨春玉, 宁芳. 文拉法辛防治不同中医证型重性抑郁障碍效果评价[J]. 预防医学, 2018, 30(5): 459-462.
LIU Lan-ying*, LUO Li-yuan, ZHU Chun-qing, WANG Pei-rong, YANG Chun-yu, NING Fang. Efficacy of venlafaxine on prophylaxis and treatment of different TCM syndrome types of major depressive disorder. Preventive Medicine, 2018, 30(5): 459-462.